0001181431-13-028130.txt : 20130516 0001181431-13-028130.hdr.sgml : 20130516 20130516071822 ACCESSION NUMBER: 0001181431-13-028130 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130515 FILED AS OF DATE: 20130516 DATE AS OF CHANGE: 20130516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH MARK L CENTRAL INDEX KEY: 0001206467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35073 FILM NUMBER: 13849464 MAIL ADDRESS: STREET 1: NABI PHARMACEUTICALS STREET 2: 5800 PARK OF COMMERCE BLVD N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gevo, Inc. CENTRAL INDEX KEY: 0001392380 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 870747704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 303-858-8358 MAIL ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C STREET 2: Suite 310 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: Gevo Inc DATE OF NAME CHANGE: 20070307 4 1 rrd380099.xml SHARES SOLD UNDER 10B5-1 PLAN X0306 4 2013-05-15 0 0001392380 Gevo, Inc. GEVO 0001206467 SMITH MARK L GEVO, INC.,345 INVERNESS DRIVE SOUTH BUILDING C, SUITE 310 ENGLEWOOD CO 80112 0 1 0 0 Chief Financial Officer Common Stock 2013-05-15 4 S 0 351 1.62 D 178910 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading adopted December 14, 2012. The shares sold represent shares of restricted stock granted to the reporting person that have recently vested. Such shares were sold to satisfy certain tax obligations of the reporting person triggered by the vesting of such shares. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.67, inclusive. The reporting person undertakes to provide to Gevo, Inc., any security holder of Gevo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. /s/ Brett Lund, Attorney-in-Fact 2013-05-16